glp 1 short term GLP-1 and Health: Beyond Weight Loss in the Ozempic Era GLP-1 Medications – Community Education

Short answer: Not usually

The cautious approach for women in their 50s with a family history of hormone-sensitive cancers is to discuss the question with both the prescribing clinician and the womans oncologist or primary care provider before initiating any peptide that elevates IGF-1

Many providers recommend continued treatment beyond this point to maintain results, as stopping semaglutide is associated with weight regain in approximately two-thirds of patients within one year of discontinuation

Consistency and precision are crucial

Substrate-selective recognitionA

Clinical evidence and how it compares to other oils